![èŠåºãç»å](https://assets.st-note.com/production/uploads/images/106402755/rectangle_large_type_2_beb55996bef5612dfb9ba8eb7574a4d0.jpeg?width=1200)
ð¥äžçäžã§å€§å€±æãç¶åºð¥å®å šæ§ã«é¢ããããŒã¿ã¯ãæããããšããèšãããããªã
å¥åº·ã®èŠç¹
ã³ãªãŒã³ã»ããŒããŒïŒè 2023幎5æ12æ¥
COVID-19ïŒã³ãŽã£ãã-ãã€ã³ãã£ãŒã³ïŒã¯ã¯ãã³ã®æå¹æ§ãåŠå®çã§ããããšãã¯ã¯ãã³ãæ¥çš®ããŠããªã人ã§ã¯ãªããæ¥çš®ãã人ãCOVID-19ã«é »ç¹ã«æ©ãŸãããçç±ã«ã€ããŠãçŸåšããã£ãŠããããšãæŽçããŠã¿ããã
COVID-19ã¯ã¯ãã³ãšããã®äžéšã§ããæ°ããäºäŸ¡ã¯ã¯ãã³ã¯ãé©ãã¹ãããšã«ãæãããã®ãªãã»ã©å®å
šã§ãªãã宣äŒãããç®çã«ã¯å¹æããªãã®ã ã
COVID-19ã¯ã¯ãã³ãå®å
šã§ããªããå¹æçã§ããªããå¯éçã§ããªãããšã¯ãäžçäžã®äžè¬äººãå»åž«ãç§åŠè
ã®éã§ãŸããŸãèªèãããããã«ãªã£ãŠããã
ãã®èšäºã§ã¯ãCOVID-19ã¯ã¯ãã³ãæãããã®ãªãã»ã©å¹æããªããããšã®åè«ã®äœå°ã®ãªã蚌æ ã瀺ãã(ãããã®ã¯ã¯ãã³ãåŠäœã«å±éºã§ãããã«ã€ããŠã¯ãç§ã®ä»ã®ãµãã¹ã¿ãã¯ã®èšäºãæ¬ãå®å
šã§ãå¹æçã§ããªãããåç
§ãã ãã)
ãèæ¯ã
2020幎æ«ã®ç±³åœã®æ»äº¡çããŒã¿ã¯ãåœæå ±åãããéå»20幎ãéããŠã®ä»ã®ããŒã¯ãšæ¯èŒããŠã2020幎ã®è¶
éæ»äº¡ã®çªåºããããŒã¯ããªãã£ãããããã³ãããã¯ã®çæãè£ä»ãããã®ã§ã¯ãªãã£ãã
CDCïŒç±³åœçŸç
管çäºé²ã»ã³ã¿ãŒïŒã®äžé£ã®æ¹èšã¯ã2020幎ã«æ»äº¡ãããšäž»åŒµãã人æ°ãç¶ç¶çã«å¢å ãããŠããã
çŸåšã§ãã4æ24æ¥çŸåšãCDCã¯2021幎12æã«æžããã1ããŒãžã§ã2020幎ã«ç±³åœã§å
šæ»å ã§æ»äº¡ãã人æ°ã¯338äž3729人ã ãšç€ºããŠãã[1]ã
ãå³å£±ãã
https://www.cdc.gov/nchs/data/databriefs/db427.pdf
ãå³åŒããhttps://www.cdc.gov/nchs/nvss/vsrr/covid19/index.htm
ãå³åãã2020幎 ç±³åœã®é±å¥è¶
éæ»äº¡çãURLãªã
2020幎æ«ãã2幎çµã£ãŠãã2020幎ã«æ»äº¡ãã人ã®æ°ã®çæãå¢ãç¶ãããšããããã©ã®æç¹ã§ãã®æ°ã確å®ããã®ã ãããã2021幎12æã«ãªã£ãŠãã2020幎ã®æ£ç¢ºãªæ»äº¡è
æ°ãCDCã«æäŸãããªãã®ã¯ãªããïŒ
ãããã®å Žåãã2020幎ïŒCOVID-19ç
åäœã®å¹ŽïŒã®æ»äº¡çã¯ã2021幎ïŒCOVID-19ã¯ã¯ãã³ã®å¹ŽïŒã®346äž4000人ãããå°ãªãã£ãã®ã ã[2]ã2020幎ã®æ»äº¡è
æ°ã¯ããã³ãããã¯ããªãã£ãéå»3幎ã®ãããããšåæ§ãç±³åœç·äººå£ã®çŽ1ïŒ
ã«ãšã©ãŸã£ãã
ç¹çãã¹ãã¯ã2020幎12æã®ç±³åœã§ã®æ»äº¡è
æ°ãå§åçã«å€ããã100幎ã«äžåºŠã®ææªã®ãã³ãããã¯ããšå®£äŒãããŠãããã®ã®ãå®éã«ã¯ãã®ãã³ãããã¯ãšèšãããææã®ç±³åœã§ã®æ»äº¡è
æ°ã¯ããããŸã§ã®11ã¶æéã®å¹³åããã32ïŒ
å€ãã£ãããšã ã
çµæžååéçºæ©æ§ãçºè¡šããããŒã¿ã«ãããšã2020幎12æã®ãã®æåŸã®3é±éã®ããããã§ãè¶
éæ»äº¡è
æ°ïŒäºæ³ãããæ»äº¡è
æ°ãäžåãæ»äº¡è
æ°ïŒãããã³ãããã¯ãšããããã®åã®ã©ã®é±ãããé«ãã£ãã®ã ã[3]
2020幎12æã®æåŸã®3é±éã¯ããããã1é±éããã25,000人ã®è¶
éæ»äº¡ãè¶
ããã®ã«å¯Ÿããææªã®COVID-19å
¥é¢é±ã§ãã2020幎4æã®æåã®2é±éã§ããã1é±éããã25,000人ã®è¶
éæ»äº¡ãè¶
ããããšã¯ãªãã£ãã
ãã¡ã€ã¶ãŒç€Ÿã®ã¯ã¯ãã³ã¯ã2020幎12æ14æ¥ã«ã¢ã¡ãªã«åœæ°ã«å
¬éãããã[4]
çŸæç¹ã§ã¯ãæ«æã®çœè¡ç
ãªã©ã®é²è¡ãããé節ãªæ«æçŸæ£ãªã©COVID-19以å€ã®çåœãè
ããç¶æ³ãé€ãããç±³åœã§COVID-19ãšèšºæãããŠæ»äº¡ããåã©ãã¯ããªããããšãç¥ãããŠããã å£ç¯æ§ã€ã³ãã«ãšã³ã¶ãé·ãèªåè»ã«åä¹ããŠããããšããCOVID-19ã®ãã©ã®äºçš®ãããåã©ããéå°å¹Žã®çåœãè
ãããšèšç®ãããŠããã
2020幎12æãã¯ã¯ãã³ã®æ¥çš®ãå¯èœã«ãªã£ãæã§ããããšã¯å¶ç¶ã§ã¯ãªããããããªãã2021幎åé ã«ã¯é¡èãªéå°æ»äº¡ãèŠãããCOVID-19ã¯ã¯ãã³ãæ°ããªèŠå ãšãªã£ãŠãããæŽã«ã2020幎1æãã11æãŸã§ã®ç±³åœã§ã®æ»äº¡è
æ°ã¯æå¹³å274,000人ã ããåãCDCã®ããŒã¿è¡šã«ãããšã2020幎12æ以éãæå¹³åã®æ»äº¡è
æ°ã¯288,250人ãšè·³ãäžãã£ãŠããã
ãã¡ã€ã¶ãŒç€Ÿã®COVID-19ã¯ã¯ãã³ã¯ã2020幎12æ14æ¥ã«åããŠç±³åœã§éå£æ¥çš®ãå¯èœã«ãªãããã®æ°æ¥åŸã«ã¢ãã«ã瀟ã¯ã¯ãã³ãçºå£²ãããã
ãžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ç€Ÿã®ã¯ã¯ãã³ãå©çšå¯èœã«ãªãã®ã¯ã2021幎2æ27æ¥ã§ããã
å
ã®ã¯ã¯ãã³ãäžæã«é
åžãããããã«ãªããšåæã«ã2020幎ã®æ®ãã®æéãç±³åœã«ãããããããåå ã«ãã1é±éãããã®æ»äº¡è
æ°ã¯ã6äž3000人ãã8äž4000人ã«æ¥å¢ããããã¯ã¯ã¯ãã³ä»¥å€ã®åå ãšã¯èãã«ããã32ïŒ
ã®å¢å ã§ããã
å
¬åŒã«å ±åãããæ°åããŸãå€ããã¬åã«CDCã®ã¹ã¯ãªãŒã³ã·ã§ããåç
§ã
ãå³èãhttps://www.cdc.gov/nchs/nvss/vsrr/provisional-tables.htm
2021幎1æã®æ»äº¡è
æ°ãããã®åŸã®5ã¶æã®ãããããšæ¯ã¹ãŠã©ãã ãé«ããã«æ³šç®ããŠæ¬²ããã
äŸå¹Žã1æã¯æ»äº¡æ°ãæãå€ãæã ãã1æã®æ»äº¡çã¯2æãã32%ãé«ãã®ã ã
CDCã®ããŒã¿ããããã¡ã€ã¶ãŒç€Ÿãšã¢ãã«ã瀟ã®ããŒã«ã¢ãŠãåŸã®æåã®7é±éã®ããããã«ãããç±³åœã§ã®1é±éãããã®æ»äº¡è
æ°ã¯ããã¹ãŠ2020幎ã®æãæ»äº¡è
æ°ã®å€ãé±ïŒ2020幎ã®4æ11æ¥ãš4æ18æ¥ã«çµãã2é±éïŒããè¶
ããŠããããšããããã[5]ã
ããã¯ãð誰ããã¯ã¯ãã³ã«ã€ããŠèºèºããã®ã«ååã§ãããè«ççã«ã¯ãCOVID-19ãããã¯ã¯ãã³ã®æ¹ãæãçã ã
ãå
¬è¡è¡çã®ãå°é家ãã¯ããŒã¿ã«å¯ŸããŠçŽ çŽã§ãªãã
COVID-19ã¯ã¯ãã³ã®å®å
šæ§ãæå¹æ§ãè©äŸ¡ããããã®äº€çµ¡å åã¯ãç±³åœçŸç
管çäºé²ã»ã³ã¿ãŒããã¯ã¯ãã³æªæ¥çš®ããšããèšèã欺çïŒããŸãïŒçã«äœ¿çšããCOVID-19ã¯ã¯ãã³ãæ¥çš®ããããšããªã人ã ãã§ãªãã7æ¥ãŸãã¯14æ¥æªæºåã«COVID-19ã¯ã¯ãã³ãæ¥çš®ããããšããã人ãå«ããŠããããšã§ãã£ãã ãã®ãçäŸã«ãŠã³ãã®çªã®åããã«ãã£ãŠãã¯ã¯ãã³æ¥çš®çŽåŸã®ææçãè² å·ãæ»äº¡ãã欺ççãªæå£ã§ãã¯ã¯ãã³æªæ¥çš®ãã®ã«ããŽãªãŒã«å²ãåœãŠãããæã«ã¯ãã®åå ã«ãããªã£ãŠããŸãã®ã ã
ãã¡ã³ã°ããžã§ãŒã³ãºãã¯ããã®ãããªæ¬ºçã«ã€ããŠããæžããŠããïŒããã®é察称æ§ã¯ãã¯ã¯ãã³æ¥çš®çŸ€ã®çäŸã¯ç¡å¹ãšãªãããã¯ã¯ãã³æªæ¥çš®çŸ€ã®çäŸã¯ç¡å¹ãšãªããã®ã§ãæšå®å€ã«åããçããã[6]
ãã®èª€åé¡ã®åé¡ç¹ã¯ãå·å®³ãšæ»äº¡ããã¹ãŠCOVID-19ã¯ã¯ãã³æ¥çš®åŸãããã€ãŸãäžã®ã°ã©ãã®ããã«æ®ãã©åæ¥ã«ããŒã¯ã«éããŠããããšã ããããããããã®äººã
ã¯ãã¯ã¯ãã³æ¥çš®åŸéããªãããããã¯ã¯ãã³æªæ¥çš®ããšãã誀ã£ãã¬ããã«ã貌ãããå ±åãããããŒã¿ã®å€ããæ··ä¹±ãããã
ãå³äŒã https://openvaers.com/covid-data/mortality
ãã®èª€åé¡ã®åé¡ã§å¯äžãè¯ãã£ãã®ã¯ã2023幎以éããã¯ããã®ãããªåé¡ã§ã¯ãªããªã£ãŠããããšã ããã®èª€èªã¯ãCOVID-19ã¯ã¯ãã³æ¥çš®ã®ããŒã¯ã§ãã£ã2021幎ããããŠ2022幎ã®å€ãã®ããŒã¿ãæ··ä¹±ãããã
2023幎çŸåšããŸã COVID-19ã¯ã¯ãã³ãæ¥çš®ããŠãã人ã¯æ®ãã©ããªããããã»ãŒå
šå¡ã14æ¥ä»¥äžåã«æ¥çš®ããããããªããã決å®ããŠããããã®é
ãææã«åºãåæãããæ£ç¢ºãªã«ããŽãªãŒã«å
¥ãããšã«ãªãããããã2020幎ãã2022幎ã«ãããŠã®ãã®éèŠãªå
¬è¡è¡çããŒã¿ã«ã€ããŠã以åã®èª€åé¡ãæçµçã«ä¿®æ£ããããããã£ãŠç Žæããå¯èœæ§ã¯ããã®æç¹ã§ã¯æ®ãã©ãªãã§ãããã
ãCOVID-19ã¯ã¯ãã³ã®æå¹æ§ãåŠå®çã§ããããšããããŠãããæå³ãããã®ã
COVID-19ã¯ã¯ãã³ã¯ãCOVID-19ã«å¯ŸããŠéåžžã«å¹æãäœããããè² ã®æå¹æ§ãæã£ãŠãããã€ãŸããã¯ã¯ãã³ãæ¥çš®ããåŸã«COVID-19ã«ããææãå
¥é¢ãããå¯èœæ§ã¯ãæ¥çš®ããªãã£ãå Žåãããé«ããªã£ãŠããã
COVID-19ã¯ã¯ãã³ã¯ãäžè¬çã«ãªãã¯ãã³ãšCOVID-19ã«ããçäŸãå
¥é¢ãæžããããšãã§ããªãã ãã§ãªããå®éã«äž¡æ¹ã®çºççãå¢å ãããŠãããCOVID-19ã¯ã¯ãã³ã®æå¹æ§ãåŠå®ãããçµæã¯ãäžçäžã§èŠãããŠããã
ãã¡ã€ã¶ãŒãšã¢ãã«ãã®èšåºè©Šéšã§ã¯ãææã®äºé²ã«ã€ããŠã¯èšåãããŠããªãã
ã¿ã«ã»ã¶ã¯ã¹ã¯ãã¢ãã«ãã®æé«å»åŠè²¬ä»»è
ã§ããã ãªããªãããã®ããã«ã¯ãé±ã«2åãéåžžã«é·ãæéã人ã
ã«ç¶¿æ£ãåœãŠãªããã°ãªãããããã¯éçšäžäžå¯èœã«ãªãããã§ããã[7]
ã©ãªãŒã»ã³ãªãŒå士ã¯ãåœç«è¡çç 究æã®COVID-19ã¯ã¯ãã³ã®èšåºè©Šéšãç£ç£ããŠããã圌ã¯2020幎11æ20æ¥ã«ããèªã£ãŠããïŒãç 究ã¯ãææãè©äŸ¡ããããã«èšèšãããŠããŸããã 圌ãã¯ãã®è³ªåãããªãããçŸæç¹ã§ã¯ããã«é¢ããæ
å ±ã¯æ¬åœã«ãªããã(圌ããã®ããã«èšã£ããšåŒçšãããèšäºã¯ã以åã¯ãªãã£ãããçŸåšã¯ãã€ãŠã©ãŒã«ã®äžã«ãã)[8]
ãæãæš©åšã®ããå»åŠéèªã瀺ãåŠå®çãªæå¹æ§ã
ããã¥ãŒã€ã³ã°ã©ã³ãã»ãžã£ãŒãã«ã»ãªãã»ã¡ãã£ã·ã³ãã«ãããšããCOVID-19ãå®å
šã«æ¥çš®ããŠããŒã¹ããã人ã¯ãSARS-CoV-2ææåŸãç
æ°£ããã®å埩ãèããé
ããããé·ãæéäŒæåãç¶æããããšã瀺ãããŠããã[9]
ãå³éžãhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258747/
ç±³åœå»åž«äŒéèªïŒJAMAïŒã«ãCOVID-19ã¯ã¯ãã³ã2å以äžæ¥çš®ãã人ã¯ã0ïœ1åæ¥çš®ãã人ã«æ¯ã¹ãŠCOVID-19ãžã®åææãå€ããåææ確çã¯æéãšãšãã«é«ããªããšããããŒã¿ãæ²èŒãããã ãé©ãã¹ãããšã«ã2å以äžã®ã¯ã¯ãã³æäžã¯ã1å以äžã®æäžãšæ¯èŒããŠãåææã®ç¢ºçããããã«é«ãããšãšé¢é£ããŠããã[10]
ãè±åœå»åŠéèªãã«æ²èŒãããåæã§ã¯ã倧åŠã®çŸ©ååãšããæèã§COVID-19ã¯ã¯ãã³ã«ãããæ£å³ã®äºæ³å人被害ããçºèŠããBNT162b2BNT162b2ã¯è質ããç²å補å€ããã¯ã¬ãªã·ã修食RNAã¯ã¯ãã³ã§ãå眮å®å®åãèåºå®SARS-CoV-2å
šé·ã¹ãã€ã¯èçœè³ªãã³ãŒãããã§è¥å¹Žæ人ãåŸæŒããããšã18ãCOVID-19ã§åé¿ãããå
¥é¢ïŒ32.0ïŒãããã100äžäººãããã®SAEïŒé倧ãªæ害äºè±¡ïŒã5åïŒ593.5ïŒå€ãããšãããŠããã ãããŠãã1åã®å
¥é¢åé¿ã«å¯ŸããŠãæã
ã¯çŽ18.5åã®SAEãš1430 - 4626åã®æ¥åžžæŽ»åã®äžæãèŠç©ãã - ããã¯ãæ¯äŸããå
¬è¡è¡çäžã®å©çã«ãã£ãŠçžæ®ºãããªãã[11]
ãã³ãŽã£ããã¯ã¯ãã³ã®åŠå®çãªæå¹æ§ã¯äžçäžã§èŠãããŠããã
ã¹ãã©ããã¢ã³ãšã¯ããŒã«ã¯68ã«åœã®COVIDã¯ã¯ãã³æ¥çš®ã調æ»ããã...åŸåç·ã¯ãå®å
šã«ã¯ã¯ãã³æ¥çš®ããã人å£ã®å²åãé«ãåœã»ã©ã100äžäººãããã®COVID-19çäŸãå€ããšãããããããªæ£ã®é¢é£ã瀺åããŠãããããšãæããã«ããã[12]
ã¹ãŠã£ãŒãããŒã¯ãã¹ãã©ããã¢ã³ãšã¯ããŒã«ã®æ°èŠCOVID-19æ£è
ãšã¯ã¯ãã³æ¥çš®ã®é¢ä¿ã«é¢ããåŸåç·ããåã«éœæ§ã§ããã ãã§ãªããã...å®éã«éåžžã«åŒ·ãéœæ§é¢é£ãããããšç€ºããã[13]
ãå³æã
https://pdmj.org/papers/Comment_on_Subramanian_and_Kumar
145ã«åœããã®ããŒã¿ã®ãã€ãºåæã«ãããšãCOVID-19ã¯ã¯ãã³ã¯ããã®ç 究ã®åºå€§ãªåœéçç¯å²ã«ãããŠã100äžäººãããã®COVID-19çäŸæ°ãš100äžäººãããã®COVID-19é¢é£æ»è
æ°ãå¢å ãããããšãããã£ãã[14] ãã®ç 究ã§ã¯ããã¯ã¯ãã³é
åã«çŽæ¥èµ·å ããCOVID-19é¢é£çäŸãšæ»äº¡ã®äž¡æ¹ãèããå¢å ããŠãã...ãããšãå€æããã
ç±³åœã§ã®çµæã¯ãCOVID-19ã¯ã¯ãã³ã«ãã100äžäººãããã®çäŸæ°[15]ã38ïŒ
å¢å ãã100äžäººãããã®æ»äº¡æ°[16]ã31ïŒ
å¢å ããŠããã
ä»ã®ç 究ã§ã¯ãã¯ã¯ãã³æ¥çš®è
ãšã¯ã¯ãã³æªæ¥çš®è
ã®éã§ãŠã€ã«ã¹éãææçã«å·®ããªãããšãå€æããã[17] [18] [19]
COVID-19ã¯ã¯ãã³ã®äžççãªæå¹æ§ã®æ¬ åŠãæŽã«ç解ããããã«ãç¹å®ã®åœã«ãããã¯ã¯ãã³ã®æå¹æ§ãåŠå®ãããçŸè±¡ã«ã€ããŠã®åæãèŠãŠã¿ããã
ã¢ã¡ãªã«ã®ã¯ãªãŒãã©ã³ãã»ã¯ãªããã¯ã®51,011人ã®åŸæ¥å¡ã察象ã«ãã調æ»ãè¡ãããã ããã«ãããšããCOVID-19ã®ãªã¹ã¯ã¯ãçŽè¿ã®COVID-19ã®å
è¡ãšããœãŒãããã®æéãã以åã«åããã¯ã¯ãã³ã®æäžåæ°ã«å¿ããŠå¢å ããããšããããšãããã£ãã[20]
次ã®ã°ã©ãã¯ãã¯ãªãŒãã©ã³ãã»ã¯ãªããã¯ã®ç 究ã®åæ¥ä»¥éãCOVID-19çŸæ£ã®çŽ¯ç©çºççã®å¢å ã瀺ããŠãããCOVID-19ã¯ã¯ãã³ã®é£ç¶æäžã«ãã£ãŠæªåããææçãæããã«çšéäŸåçã«å¢å ããŠãããã¯ã¯ãã³æªæ¥çš®è
ã¯ã¯ã¯ãã³æ¥çš®ãåããååãããCOVID-19ç
ãã¯ããã«å°ãªãããšããããã
å³ã®å°ããªæåã«ã¯ãäžããé ã«
ãé»è²ã3å以äžã®æäžãšæžãããŠããã
ãéåã3åããç·åã2åããèµ€åã1åã
ãé»åã0åãšããã
ãå³æããhttps://www.medrxiv.org/content/10.1101/2022.12.17.22283625v5.full.pdf
ãªãã¯ã¹ãã©ãŒã倧åŠããããã ã®ç
é¢ã¹ã¿ãã900人ã察象ã«è¡ã£ã調æ»ã§ã¯ãã¯ã¯ãã³æ¥çš®ãåããææè
ïŒããã¬ãŒã¯ã¹ã«ãŒãææè
ïŒã®ãŠã€ã«ã¹éã®ããŒã¯ã¯ãã¯ã¯ãã³æªæ¥çš®ã®ã¹ã¿ããã®251åã§ããããšã瀺ãããã[21]
ãã®ãã³ããŒã¯ã®ç 究[22]ã§ã¯ããã¡ã€ã¶ãŒãšã¢ãã«ãã®COVID-19ã¯ã¯ãã³ã®äž¡æ¹ããæäžåŸããã90æ¥ä»¥å
ã«ãªãã¯ãã³å€çš®ã«å¯ŸããŠè² ã®å¹åã瀺ãããã®å¹åäœäžã¯ãåæã®ãã«ã¿å€çš®ããããªãã¯ãã³ã§æŽã«éãã£ãããšã瀺ããããã®
æ¥æ¿ãªæžå°ã¯ã次ã®ã°ã©ãã«ç€ºãããŠããã
ãå³çããhttps://www.medrxiv.org/content/10.1101/2021.12.20.21267966v3.full.pdf
äžèšã®ã°ã©ããããmRNA COVID-19ã¯ã¯ãã³ã¯ããããã90æ¥ãéãããšãæå¹æ§ãäœäžããããããªãã¯ãã³ææã®ãªã¹ã¯ãé«ãŸãããšããããã
ãã³ããŒã¯ã§ãªãã¯ãã³ã«ææãã人ã®89.7%ã¯ããå®å
šæ¥çš®ããŸãã¯ãååããŒã¹ã¿ãŒããåããŠããã調æ»æç¹ã§ã¯ããã³ããŒã¯åœæ°ã®77.9%ãå®å
šãªã¯ã¯ãã³æ¥çš®ãåããŠããã[23] ãããã£ãŠããã³ããŒã¯ã§ã¯ã¯ã¯ãã³æ¥çš®è
ã¯ã¯ã¯ãã³æªæ¥çš®è
ããããªãã¯ãã³ã«ææããããäœè³ªã§ãã£ãã
è±åœæ¿åºã®åœå®¶çµ±èšå±ããŒã¿ã§ã¯ãäžè¡šã®ããã«ãã¯ã¯ãã³ãæ¥çš®ãããã³ã«ãªãã¯ãã³å€ç°äœéœæ§ãšãªãå¯èœæ§ãé«ããªããã¯ã¯ãã³å¹æãåŠå®çã§ããããšã瀺ãããŠããã[24]ã[25]以äžã®è¡šãèŠãã«ã¯ãExcelãã¡ã€ã«ãã¯ãªãã¯ããå¿
èŠãããïŒ
ãå³æŸã
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/adhocs/14107coronaviruscovid19infectionsurveyukcharacteristicsrelatedtohavinganomicroncompatibleresultinthosewhotestpositiveforcovid19
ã¢ã€ã«ã©ã³ãã®éå£ã¬ãã«ã§ã¯ã倧éã¯ã¯ãã³æ¥çš®ãšCOVID-19çäŸã®åçãªäžæã«ã¿ã€ãã³ã°ãçžé¢ããŠãããã¢ã€ã«ã©ã³ãã§ã¯ãæ人人å£ã«ãããã¯ã¯ãã³ã®æ®åçãæãé«ãã2022幎1æ22æ¥æç¹ã§94.8ïŒ
ãå®å
šã«ã¯ã¯ãã³æ¥çš®ãåããŠããããCOVID-19çäŸã¯ã¯ã¯ãã³ã䜿çšãããåã®1æã«æ¯ã¹ãŠ317ïŒ
äžæããã[26]
ã¹ã³ããã©ã³ãã§ãããã®è¡š[27]ãšã°ã©ãã«èŠãããããã«ãã¯ã¯ãã³ã1åã2åã3åæ¥çš®ãã人ããããã¯å
šãæ¥çš®ããŠããªã人ã®äžã§ãã¯ã¯ãã³æªæ¥çš®è
ã¯4ã€ã®ã°ã«ãŒãã®äžã§2022幎1æã®æ£è
çãæãäœããªã£ãŠããã[28]
ãå³æŸå£±ãã
https://publichealthscotland.scot/media/11802/22-01-19-covid19-winter_publication_report_revised.pdf
ãå³æŸåŒã ãhttps://publichealthscotland.scot/media/11802/22-01-19-covid19-winter_publication_report_revised.pdf
ä»ã®2ã€ã®éåžžã«ã¯ã¯ãã³æ¥çš®ã®å€ãåœã§ã¯ãéå£æ¥çš®åŸã«æ£è
æ°ãæ¥å¢ããã以äžãéåœãšãã€ãïŒ[29]ã
ãå³æŸåãããžã§ã³ãºã»ãããã³ã¹å€§åŠããŒã¿ã§èŠãç§ãã¡ã®äžç
ã
2021幎12æ31æ¥ã«ãã€ãã§çºçãã4,020äŸã®ãªãã¯ãã³ã調æ»ãããšããããã®ãã¡1,137äŸãããŒã¹ããããŠããããšãå€æãããã¯ã¯ãã³æªæ¥çš®ã®ãªãã¯ãã³çäŸã¯1097äŸã®ã¿ã ã£ãã[30] [31]
ãããã2021幎12æ31æ¥æç¹ã®ãã€ãã§ã¯ããããŒã¹ãããå®å
šæ¥çš®ããæªæ¥çš®ãã®3ã€ã®ã«ããŽãªãŒã«åçšåºŠã®äººæ°ãååšããããšã«ãªãããã€ãæ¿åºã®è¶
éæ»äº¡çããŒã¿ãç 究ããŠãããã€ãã®ç§åŠè
ã¯ãã¯ã¯ãã³æ¥çš®çãé«ãã»ã©è¶
éæ»äº¡çãé«ããªãããšã芳å¯ããã[32]
ãã®ããã«ãåœæäžçäžã§æµè¡ããŠããCOVID-19æ ªã§ãããªãã¯ãã³ã«å¯ŸããŠãã¯ã¯ãã³æªæ¥çš®è
ã¯åŒ·ãã¢ããã³ããŒãžïŒåªäœãæå©ãªç«å Žãå©çãïŒãæã£ãŠããããšããããã
ãã«ã¿æ ªã«å¯ŸããŠãCOVID-19ã¯ã¯ãã³ã¯å¹ããªãã
2021幎7æãã¢ã¡ãªã«ã®ããµãã¥ãŒã»ããå·ã§ããã«ã¿ãåªå¢ã ã£ãææãšå Žæã§ãåèš469人ã®æ°ããCOVID-19æ£è
ã®ãã¡ã346人ïŒ74ïŒ
ïŒãäžéšãŸãã¯å®å
šã«ã¯ã¯ãã³ãæ¥çš®ãã人ã§ãæ¥çš®è
ã®ãã¡274人ãçç¶ãåºãŠããã[33]
ã€ã³ãã®ããªãŒã§ã¯ãç
é¢ã§ã®ãªãã¯ãã³çäŸ34人ã®ãã¡ã33人ãå®å
šã¯ã¯ãã³æ¥çš®è
ã§ãã£ãïŒ97ïŒ
ïŒãããããã€ã³ãã®COVID-19ã®æ¥çš®çã¯åœæ40%ã«éããªãã£ãã[34]
ãã¡ã€ã¶ãŒãšã¢ãã«ãã®äž¡ã¯ã¯ãã³ã¯ãæ°ã«æã§æå¹æ§ããã€ãã¹ã«æ¥èœããããšãå€æããã[35] [36] [37]
ãã¯ã¯ãã³ã¯ã¯ãã³ã®äžçã«ãããè² ã®å¹åã®æå³ãããã®ã
ã«ã¿ãŒã«ã§è¡ããããã§ãã€ããªãŒãã«ããç 究ã§ã¯ãã¯ã¯ãã³æ¥çš®ã®æç¡ãšCOVID-19ã®çºç
ããŒã¿ãå
¥æã§ãã200äžäººä»¥äžã察象ã«ãå
è¡ç 究ãšåæ§ã«ãæ¥çš®åŸæ°ã¶æã§å¹æããŒããããã€ãã¹ã«ãªãããšãæããã«ãªã£ããèè
ãã¯ããã®æžå°ããå
ç«å·ã蟌ã¿ããæ°ãããªãã¯ãã³äºçš®ã«å¯ŸããããŒã¹ã¿ãŒã¯ã¯ãã³æ¥çš®è
ã®é²åŸ¡ãäœäžããããããã§ãããšããŠãããèè
ãã¯ãã®ã¡ã«ããºã ãæŽã«èª¬æãããããŒã¹ã¿ãŒãå
ç«åå¿ãèšç·Žããç¹å®ã®çããã¬ãªãã¯ãã³ãã£ã¬ã³ãžãæåŸ
ããããã«ãªã£ãå¯èœæ§ãããã[38]
ãæåæ§ã®å眪ã
OASã¯ãã¯ã¯ãã³æ¥çš®è
ãè¡æ¶²ã«æãå ãããšããééã£ãæ¹æ³ã§æªåããããšèãããããäžæ¹ãäœã¯ãæ°ãã埮çç©ã«ç«ã¡åããããã«ãè¡æ¶²ããã§ã¯ãªããåŒåžåšããå
¥ãããã«æºåãããŠããã
ããCOVID-19ã¯ã¯ãã³ããçŸåšãã«ã¿åããªãã¯ãã³åãšåŒã°ãã颚éªã®ãªã¹ã¯ãé«ããã ããªããç§ãã¡ã¯ãããã®ã¯ã¯ãã³ã軜èã§è¿·ä¿¡çãªè¡çºãšããŠç¬ãé£ã°ãããšãã§ãããããããªãããããå®å
šæ§ã«é¢ããããŒã¿ã¯æããããã®ã°ããã§ããã
ã³ãªãŒã³ã»ããŒããŒã®ãµãã¹ã¿ãã¯ãhttps://colleenhuber.substack.com/p/a-colossal-failure-around-the-worldãããåæ²èŒã
èšæ£ïŒã°ã©ãã®ãªã³ã¯å
ïŒ"N Shrestha, P Burke, et al. "ã®ãªã³ã¯ãææ°çã«æŽæ°ããã
åèæç®[æ°å] âèšäºåç
§
ãšããã¯ã¿ã€ã ãº/TheEpochTimes
https://lists.youmaker.com/links/oXuWCo7Qi/sPLsIDpr1R/K4fYg2LpvM/rWlkJNY0b
ãMacine Translator[Brave/DeepL]ðºðžâ€ð¯ðµç¿»èš³ã
QArmyJapanFlynnå
¬åŒããŒã ããŒãž
http://bit.ly/3QzjIQF
Eriãããã©ã㌠@EriQmapJapan
EriïŒQmapJapan
https://t.me/EriAndQmapJapan
EriChat
https://t.me/joinchat/wgUQKKmwlBBmNGU1
QArmyJapanFlynn OFFICIAL Telegram Channel
https://t.me/QArmyJapanFlynn
QArmyJapanFlynnChat
https://t.me/QArmyJapanFlynnChat
JapanGreenDragon
https://t.me/joinchat/xqUZvIe1uYg1YTQx
QAJFè³æ通
https://t.me/qajfhistory
QAJFåç»ãã£ã³ãã«
https://mediable.jp/channels/a1702ee5-1e80-42b3-b5cd-bfb2f0a479b0
QAJFå
¬åŒLINE
æ€çŽ¢ID@339jejrl
https://liff.line.me/1645278921-kWRPP32q/?accountId=339jejrl
Eriãããµãã¹ã¿ãã¯
https://eriqmapjapan.substack.com/p/7f0?s=w
Eriããmediable
https://mediable.jp/channels/a1702ee5-1e80-42b3-b5cd-bfb2f0a479b0
ã¬ãããã«ã©ãžãªã·ã§ãŒ
åžå·ããã 83.0FM
æ¯æ 第ïŒïœ¥ 第ïŒæ¥ææ¥22:30ïœ23:00
http://www.fmu.co.jp/redpillradio.html
åã¯ãã¡ããã
https://www.jcbasimul.com/?radio=fmããã
éå»æŸéåãèŽãé ããŸãã
ã¡ãã£ã¢ãã«ïŒEriQmapJapan
https://mediable.jp/channels/a1702ee5-1e80-42b3-b5cd-bfb2f0a479b0?uc=qSHL6c
ã¬ãããã«ã©ãžãªã·ã§ãŒããŒã ããŒãžãæ°ãããªããŸããã
http://redpill-radio.tokyo/
![](https://assets.st-note.com/img/1684933808172-2kmBQNrdbt.jpg?width=1200)